Aminopeptidase N as a potential drug target

Aminopeptidase N (APN) is a broad specificity zinc metallopeptidase with many functions that do not always depend on its enzymatic activity. Among others, it is involved in tumor angiogenesis and metastasizing and also serves as a cellular receptor of some coronaviruses. Some APN inhibitors, such as...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EUROPEAN PHARMACEUTICAL JOURNAL Ročník 70; číslo 2; s. 52 - 53
Hlavní autoři: Farsa, Oldřich, Ballayová, Veronika, Žáčková, Radka, Zubáč, Peter
Médium: Journal Article
Jazyk:angličtina
Vydáno: Warsaw Sciendo 01.12.2023
De Gruyter Brill Sp. z o.o., Paradigm Publishing Services
Témata:
aminopeptidase N
anti-infectious activity
antitumor activity
Cancer therapies
Coronaviruses
Drug dosages
inhibitors
Leukemia
Medical research
Tumors
ISSN:2453-6725, 2453-6725
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Aminopeptidase N (APN) is a broad specificity zinc metallopeptidase with many functions that do not always depend on its enzymatic activity. Among others, it is involved in tumor angiogenesis and metastasizing and also serves as a cellular receptor of some coronaviruses. Some APN inhibitors, such as bestatin or tosedostat, were used or tested as anticancer drugs in the past. Within the past two decades, we have prepared several series of potential APN inhibitors. Some of them reached interesting values of inhibitory activity and were also successfully tested for antiproliferation activity in cancer cell lines. We also performed some QSAR studies with APN inhibitors prepared by us and other authors.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:2453-6725
2453-6725
DOI:10.2478/afpuc-2024-0002